Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSF Pharmacokinetics of Ondansetron
NCT02901054Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ondansetron in neuropathic pain, sponsored by Washington University School of Medicine. Primary endpoint: Cerebrospinal Fluid to Plasma Concentration Ratio. Started Aug 2016; status: completed.
02
Drugs
ondansetron
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02901054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02901054.